Abstract
BackgroundDigital tools provide a unique opportunity to increase access to eye care. We developed a Web-based test that measures visual acuity and both spherical and cylindrical refractive errors. This test is Conformité Européenne marked and available on the Easee website. The purpose of this study was to compare the efficacy of this Web-based tool with traditional subjective manifest refraction in a prospective open-label noninferiority clinical trial.ObjectiveThe aim of this study was to evaluate the outcome of a Web-based refraction compared with a manifest refraction (golden standard).MethodsHealthy volunteers from 18 to 40 years of age, with a refraction error between –6 and +4 diopter (D), were eligible. Each participant performed the Web-based test, and the reference test was performed by an optometrist. An absolute difference in refractive error of <0.5 D was considered noninferior. Reliability was assessed by using an intraclass correlation coefficient (ICC). Both uncorrected and corrected visual acuity were measured.ResultsA total of 200 eyes in 100 healthy volunteers were examined. The Web-based assessment of refractive error had excellent correlation with the reference test (ICC=0.92) and was considered noninferior to the reference test. Uncorrected visual acuity was similar with the Web-based test and the reference test (P=.21). Visual acuity was significantly improved using the prescription obtained by using the Web-based tool (P<.01). The Web-based test provided the best results in participants with mild myopia (ie, <3 D), with a mean difference of 0.02 (SD 0.49) D (P=.48) and yielding a corrected visual acuity of >1.0 in 90% (n=77) of participants.ConclusionsOur results indicate that Web-based eye testing is a valid and safe method for measuring visual acuity and refractive error in healthy eyes, particularly for mild myopia. This tool can be used for screening purposes, and it is an easily accessible alternative to the subjective manifest refraction test.Trial RegistrationClinicaltrials.gov NCT03313921; https://clinicaltrials.gov/ct2/show/NCT03313921.
Highlights
BackgroundGlobally, approximately 60% of individuals require a visual aid, such as spectacles or contact lenses, for proper visual acuity [1,2]
We present the results of the Manifest versus Online Refraction Evaluation (MORE) trial, a study designed to validate this Web-based refractive assessment by comparing the outcome between the Web-based test and the subjective manifest refraction test, focusing on corrected visual acuity achieved by using the prescription obtained from the Web-based test
J Med Internet Res 2019 | vol 21 | iss. 11 | e14808 | p. 9. In this noninferiority clinical trial, we compared a Web-based tool for measuring refractive error with the current gold standard, the subjective manifest refraction
Summary
BackgroundGlobally, approximately 60% of individuals require a visual aid, such as spectacles or contact lenses, for proper visual acuity [1,2]. To increase access to refractive testing, the Dutch company Easee BV in Amsterdam, the Netherlands, developed an algorithm-based Web-based tool that measures the refractive state of the eye by using a smartphone and computer screen. We developed a Web-based test that measures visual acuity and both spherical and cylindrical refractive errors This test is Conformité Européenne marked and available on the Easee website. Conclusions: Our results indicate that Web-based eye testing is a valid and safe method for measuring visual acuity and refractive error in healthy eyes, for mild myopia. This tool can be used for screening purposes, and it is an accessible alternative to the subjective manifest refraction test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have